[1] |
DRINKWATER J J, DAVIS T M E, DAVIS W A. The relationship between carotid disease and retinopathy in diabetes:a systematic review[J]. Cardiovasc Diabetol, 2020, 19(1):54. DOI: 10.1186/s12933-020-01023-6.
|
[2] |
KERNAN W N, OVBIAGELE B, BLACK H R,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(7):2160-2236. DOI: 10.1161/STR.0000000000000024.
|
[3] |
World Health Organization. Definition,diagnosis and classification of diabetes mellitus and its complications:report of a WHO consultation. Part 1,Diagnosis and classification of diabetes mellitus[R/OL]. [2018-08-19]. Geneva:World Health Organization,1999.
|
[4] |
|
[5] |
WILLEIT P, TSCHIDERER L, ALLARA E,et al. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk:meta-analysis of 119 clinical trials involving 100 667 patients[J]. Circulation, 2020, 142(7):621-642. DOI: 10.1161/CIRCULATIONAHA.120.046361.
|
[6] |
SONG P G, XIA W, ZHU Y J,et al. Prevalence of carotid atherosclerosis and carotid plaque in Chinese adults:a systematic review and meta-regression analysis[J]. Atherosclerosis, 2018, 276:67-73. DOI: 10.1016/j.atherosclerosis.2018.07.020.
|
[7] |
COPPOLA T, BERAUD-DUFOUR S, LEBRUN P,et al. Bridging the gap between diabetes and stroke in search of high clinical relevance therapeutic targets[J]. Neuromolecular Med, 2019, 21(4):432-444. DOI: 10.1007/s12017-019-08563-5.
|
[8] |
NAYLOR A R, RICCO J B, DE BORST G J,et al. Editor's choice - management of atherosclerotic carotid and vertebral artery disease:2017 clinical practice guidelines of the European society for vascular surgery (ESVS)[J]. Eur J Vasc Endovasc Surg, 2018, 55(1):3-81. DOI: 10.1016/j.ejvs.2017.06.021.
|
[9] |
SAFRI L S, LIP H T C, SARIPAN M I,et al. Older age and duration of exposure to type 2 diabetes in selective screening of asymptomatic carotid artery stenosis for primary stroke prevention-a single institution experience[J]. Prim Care Diabetes, 2020, 14(4):364-369. DOI: 10.1016/j.pcd.2019.10.001.
|
[10] |
SULTANA N,ISLAM M R. Doppler evaluation of carotid vessels in type 2 diabetes[J]. Mymensingh Med J,2020,29(3):572-578.
|
[11] |
PEARCE I, SIMÓ R, LÖVESTAM-ADRIAN M,et al. Association between diabetic eye disease and other complications of diabetes:implications for care. A systematic review[J]. Diabetes Obes Metab, 2019, 21(3):467-478. DOI: 10.1111/dom.13550.
|
[12] |
SIMÓ R, BAÑERAS J, HERNÁNDEZ C,et al. Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease:baseline results of the PRECISED study[J]. BMJ Open Diabetes Res Care, 2019, 7(1):e000845. DOI: 10.1136/bmjdrc-2019-000845.
|
[13] |
GAO L, ZHAO W, YANG J K,et al. Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease[J]. Diabetol Metab Syndr, 2021, 13(1):48. DOI: 10.1186/s13098-021-00666-z.
|
[14] |
SCHENONE A L, COHEN A, SHISHEHBOR M H. Asymptomatic carotid artery disease:a personalized approach to management[J]. Cleve Clin J Med, 2015, 82(12):855-863. DOI: 10.3949/ccjm.82a.14144.
|
[15] |
VOUILLARMET J, HELFRE M, MAUCORT-BOULCH D,et al. Carotid atherosclerosis progression and cerebrovascular events in patients with diabetes[J]. J Diabetes Complications, 2016, 30(4):638-643. DOI: 10.1016/j.jdiacomp.2016.01.022.
|
[16] |
DRINKWATER J J, DAVIS T M E, HELLBUSCH V,et al. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes:the Fremantle Diabetes Study Phase Ⅱ[J]. Cardiovasc Diabetol, 2020, 19(1):43. DOI: 10.1186/s12933-020-01018-3.
|
[17] |
XIAO Y Y, YUAN M K, XI P,et al. Relationship between carotid plaque and diabetic retinopathy in type 2 diabetes mellitus patients[J]. Zhonghua Yi Xue Za Zhi, 2017, 97(24):1871-1874. DOI: 10.3760/cma.j.issn.0376-2491.2017.24.006.
|
[18] |
|
[19] |
CEGLA J, FRANCE M, MARCOVINA S M,et al. Lp(a):when and how to measure it[J]. Ann Clin Biochem, 2021, 58(1):16-21. DOI: 10.1177/0004563220968473.
|
[20] |
WU M F, XU K Z, GUO Y G,et al. Lipoprotein(a) and atherosclerotic cardiovascular disease:current understanding and future perspectives[J]. Cardiovasc Drugs Ther, 2019, 33(6):739-748. DOI: 10.1007/s10557-019-06906-9.
|
[21] |
O'DONOGHUE M L, FAZIO S, GIUGLIANO R P,et al. Lipoprotein(a),PCSK9 inhibition,and cardiovascular risk[J]. Circulation, 2019, 139(12):1483-1492. DOI: 10.1161/CIRCULATIONAHA.118.037184.
|
[22] |
HIPPE D S, PHAN B A P, SUN J,et al. Lp(a) (lipoprotein(a)) levels predict progression of carotid atherosclerosis in subjects with atherosclerotic cardiovascular disease on intensive lipid therapy:an analysis of the AIM-HIGH (atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides:impact on global health outcomes) carotid magnetic resonance imaging substudy-brief report[J]. Arterioscler Thromb Vasc Biol, 2018, 38(3):673-678. DOI: 10.1161/ATVBAHA.117.310368.
|
[23] |
VAN DAM-NOLEN D H K, VAN DIJK A C, CROMBAG G A J C,et al. Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery:the Plaque at RISK (PARISK) study[J]. Atherosclerosis, 2021, 329:22-29. DOI: 10.1016/j.atherosclerosis.2021.06.004.
|
[24] |
BOS S, DUVEKOT M H C, TOUW-BLOMMESTEIJN A C,et al. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia[J]. Atherosclerosis, 2015, 242(1):226-229. DOI: 10.1016/j.atherosclerosis.2015.07.024.
|
[25] |
SUN D, ZHOU B Y, ZHAO X,et al. Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia[J]. J Clin Lab Anal, 2018, 32(7):e22442. DOI: 10.1002/jcla.22442.
|
[26] |
FRANK R N. Diabetic retinopathy and systemic factors[J]. Middle East Afr J Ophthalmol, 2015, 22(2):151-156. DOI: 10.4103/0974-9233.154388.
|
[27] |
BEK T. Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema[J]. Diabetologia, 2020, 63(11):2462-2470. DOI: 10.1007/s00125-020-05234-0.
|
[28] |
WAT N, WONG R L, WONG I Y. Associations between diabetic retinopathy and systemic risk factors[J]. Hong Kong Med J, 2016, 22(6):589-599. DOI: 10.12809/hkmj164869.
|
[29] |
MÁRQUEZ D F, RUIZ-HURTADO G, SEGURA J,et al. Microalbuminuria and cardiorenal risk:old and new evidence in different populations[J]. F1000 Research, 2019, 8:F1000FacultyRev-1659. DOI: 10.12688/f1000research.17212.1.
|